Javascript doit fonctionner ! Activez-le et rechargez cette page.
Le Rézo de JeuxDeMots
• Types de relations
• Types de noeuds
• Consolider
le terme
  Options  
             

  Filtrage type relations : +   - (ex: 4, 12, 18, 36, 444, 555, 777)
  Filtrage valeur :          min   max
  Filtrage type noeuds :   +   - (ex: 4, 6, 8, 9, 10, 12, 18, 36, 444, 555, 777)

  Présentation de sortie :   (ex: -rien-, cloud, nicecloud)
 

'en:quadrosilan'
(id=6898628 ; fe=en:quadrosilan ; type=1 ; niveau=200 ; luminosité=25 ; somme entrante=1741 creation date=2017-06-25 touchdate=2025-07-16 16:19:24.000)
≈ 51 relations sortantes

  1. en:quadrosilan -- r_associated #0: 43 / 1 -> en:cyproterone
    n1=en:quadrosilan | n2=en:cyproterone | rel=r_associated | relid=0 | w=43
  2. en:quadrosilan -- r_associated #0: 41 / 0.953 -> en:topilutamide
    n1=en:quadrosilan | n2=en:topilutamide | rel=r_associated | relid=0 | w=41
  3. en:quadrosilan -- r_associated #0: 36 / 0.837 -> en:zinc oxide 50 mg/ml rectal cream
    n1=en:quadrosilan | n2=en:zinc oxide 50 mg/ml rectal cream | rel=r_associated | relid=0 | w=36
  4. en:quadrosilan -- r_associated #0: 35 / 0.814 -> en:bifluranol
    n1=en:quadrosilan | n2=en:bifluranol | rel=r_associated | relid=0 | w=35
  5. en:quadrosilan -- r_associated #0: 35 / 0.814 -> en:cioteronel
    n1=en:quadrosilan | n2=en:cioteronel | rel=r_associated | relid=0 | w=35
  6. en:quadrosilan -- r_associated #0: 35 / 0.814 -> en:nilandron
    n1=en:quadrosilan | n2=en:nilandron | rel=r_associated | relid=0 | w=35
  7. en:quadrosilan -- r_associated #0: 35 / 0.814 -> en:nonsteroidal anti-androgens
    n1=en:quadrosilan | n2=en:nonsteroidal anti-androgens | rel=r_associated | relid=0 | w=35
  8. en:quadrosilan -- r_associated #0: 34 / 0.791 -> en:2-hydroxyflutamide depot
    n1=en:quadrosilan | n2=en:2-hydroxyflutamide depot | rel=r_associated | relid=0 | w=34
  9. en:quadrosilan -- r_associated #0: 34 / 0.791 -> en:benorterone
    n1=en:quadrosilan | n2=en:benorterone | rel=r_associated | relid=0 | w=34
  10. en:quadrosilan -- r_associated #0: 32 / 0.744 -> en:steroidal antiandrogen
    n1=en:quadrosilan | n2=en:steroidal antiandrogen | rel=r_associated | relid=0 | w=32
  11. en:quadrosilan -- r_associated #0: 32 / 0.744 -> en:triptorelin
    n1=en:quadrosilan | n2=en:triptorelin | rel=r_associated | relid=0 | w=32
  12. en:quadrosilan -- r_associated #0: 31 / 0.721 -> en:abiraterone
    n1=en:quadrosilan | n2=en:abiraterone | rel=r_associated | relid=0 | w=31
  13. en:quadrosilan -- r_associated #0: 31 / 0.721 -> en:androgen receptor antagonist trc253
    n1=en:quadrosilan | n2=en:androgen receptor antagonist trc253 | rel=r_associated | relid=0 | w=31
  14. en:quadrosilan -- r_associated #0: 31 / 0.721 -> en:androgen receptor inhibitor epi-506
    n1=en:quadrosilan | n2=en:androgen receptor inhibitor epi-506 | rel=r_associated | relid=0 | w=31
  15. en:quadrosilan -- r_associated #0: 31 / 0.721 -> en:enobosarm
    n1=en:quadrosilan | n2=en:enobosarm | rel=r_associated | relid=0 | w=31
  16. en:quadrosilan -- r_associated #0: 30 / 0.698 -> en:delanterone
    n1=en:quadrosilan | n2=en:delanterone | rel=r_associated | relid=0 | w=30
  17. en:quadrosilan -- r_associated #0: 30 / 0.698 -> en:dimethicone 20 mg/ml topical cream
    n1=en:quadrosilan | n2=en:dimethicone 20 mg/ml topical cream | rel=r_associated | relid=0 | w=30
  18. en:quadrosilan -- r_associated #0: 30 / 0.698 -> en:enzalutamide
    n1=en:quadrosilan | n2=en:enzalutamide | rel=r_associated | relid=0 | w=30
  19. en:quadrosilan -- r_associated #0: 30 / 0.698 -> en:epitestosterone
    n1=en:quadrosilan | n2=en:epitestosterone | rel=r_associated | relid=0 | w=30
  20. en:quadrosilan -- r_associated #0: 29 / 0.674 -> en:5-alpha reductase inhibitor [epc]
    n1=en:quadrosilan | n2=en:5-alpha reductase inhibitor [epc] | rel=r_associated | relid=0 | w=29
  21. en:quadrosilan -- r_associated #0: 29 / 0.674 -> en:abiraterone acetate
    n1=en:quadrosilan | n2=en:abiraterone acetate | rel=r_associated | relid=0 | w=29
  22. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:ar antagonist bms-641988
    n1=en:quadrosilan | n2=en:ar antagonist bms-641988 | rel=r_associated | relid=0 | w=27
  23. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:canrenoic acid
    n1=en:quadrosilan | n2=en:canrenoic acid | rel=r_associated | relid=0 | w=27
  24. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:cyp17 inhibitor cfg920
    n1=en:quadrosilan | n2=en:cyp17 inhibitor cfg920 | rel=r_associated | relid=0 | w=27
  25. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:finasteride
    n1=en:quadrosilan | n2=en:finasteride | rel=r_associated | relid=0 | w=27
  26. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:inocoterone acetate
    n1=en:quadrosilan | n2=en:inocoterone acetate | rel=r_associated | relid=0 | w=27
  27. en:quadrosilan -- r_associated #0: 27 / 0.628 -> en:proxalutamide
    n1=en:quadrosilan | n2=en:proxalutamide | rel=r_associated | relid=0 | w=27
  28. en:quadrosilan -- r_associated #0: 26 / 0.605 -> en:androgen antagonist apc-100
    n1=en:quadrosilan | n2=en:androgen antagonist apc-100 | rel=r_associated | relid=0 | w=26
  29. en:quadrosilan -- r_associated #0: 26 / 0.605 -> en:oral microencapsulated diindolylmethane
    n1=en:quadrosilan | n2=en:oral microencapsulated diindolylmethane | rel=r_associated | relid=0 | w=26
  30. en:quadrosilan -- r_associated #0: 20 / 0.465 -> cyprotérone
    n1=en:quadrosilan | n2=cyprotérone | rel=r_associated | relid=0 | w=20
  31. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:5 alpha-reductase inhibitor
    n1=en:quadrosilan | n2=en:5 alpha-reductase inhibitor | rel=r_associated | relid=0 | w=20
  32. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:amadinone
    n1=en:quadrosilan | n2=en:amadinone | rel=r_associated | relid=0 | w=20
  33. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:androgen receptor antagonist arn-509
    n1=en:quadrosilan | n2=en:androgen receptor antagonist arn-509 | rel=r_associated | relid=0 | w=20
  34. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:androgen receptor antagonist shr3680
    n1=en:quadrosilan | n2=en:androgen receptor antagonist shr3680 | rel=r_associated | relid=0 | w=20
  35. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:androgen receptor antagonists
    n1=en:quadrosilan | n2=en:androgen receptor antagonists | rel=r_associated | relid=0 | w=20
  36. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:androgen receptor downregulator azd3514
    n1=en:quadrosilan | n2=en:androgen receptor downregulator azd3514 | rel=r_associated | relid=0 | w=20
  37. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:androgen receptor inhibitor
    n1=en:quadrosilan | n2=en:androgen receptor inhibitor | rel=r_associated | relid=0 | w=20
  38. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:ar antagonist odm-201
    n1=en:quadrosilan | n2=en:ar antagonist odm-201 | rel=r_associated | relid=0 | w=20
  39. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:avobenzone 20 mg in 1 ml / octinoxate 70 mg in 1 ml / oxybenzone 50 mg in 1 ml topical cream [soothing day spf 15]
    n1=en:quadrosilan | n2=en:avobenzone 20 mg in 1 ml / octinoxate 70 mg in 1 ml / oxybenzone 50 mg in 1 ml topical cream [soothing day spf 15] | rel=r_associated | relid=0 | w=20
  40. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:bicalutamide
    n1=en:quadrosilan | n2=en:bicalutamide | rel=r_associated | relid=0 | w=20
  41. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:cyp17 inhibitor vt-464
    n1=en:quadrosilan | n2=en:cyp17 inhibitor vt-464 | rel=r_associated | relid=0 | w=20
  42. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:cyp17 lyase inhibitor asn001
    n1=en:quadrosilan | n2=en:cyp17 lyase inhibitor asn001 | rel=r_associated | relid=0 | w=20
  43. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:dutasteride
    n1=en:quadrosilan | n2=en:dutasteride | rel=r_associated | relid=0 | w=20
  44. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:hydroxyflutamide
    n1=en:quadrosilan | n2=en:hydroxyflutamide | rel=r_associated | relid=0 | w=20
  45. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:octinoxate 75 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 25 mg in 1 ml topical cream [matte moisturizer spf 15]
    n1=en:quadrosilan | n2=en:octinoxate 75 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 25 mg in 1 ml topical cream [matte moisturizer spf 15] | rel=r_associated | relid=0 | w=20
  46. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:osaterone
    n1=en:quadrosilan | n2=en:osaterone | rel=r_associated | relid=0 | w=20
  47. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:quillaja saponaria bark
    n1=en:quadrosilan | n2=en:quillaja saponaria bark | rel=r_associated | relid=0 | w=20
  48. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:topterone
    n1=en:quadrosilan | n2=en:topterone | rel=r_associated | relid=0 | w=20
  49. en:quadrosilan -- r_associated #0: 20 / 0.465 -> en:zanoterone
    n1=en:quadrosilan | n2=en:zanoterone | rel=r_associated | relid=0 | w=20
  50. en:quadrosilan -- r_associated #0: 20 / 0.465 -> enzalutamide
    n1=en:quadrosilan | n2=enzalutamide | rel=r_associated | relid=0 | w=20
  51. en:quadrosilan -- r_associated #0: 20 / 0.465 -> finastéride
    n1=en:quadrosilan | n2=finastéride | rel=r_associated | relid=0 | w=20
≈ 59 relations entrantes

  1. cyprotérone --- r_associated #0: 97 --> en:quadrosilan
    n1=cyprotérone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=97
  2. en:cyproterone --- r_associated #0: 95 --> en:quadrosilan
    n1=en:cyproterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=95
  3. enzalutamide --- r_associated #0: 67 --> en:quadrosilan
    n1=enzalutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=67
  4. en:enzalutamide --- r_associated #0: 64 --> en:quadrosilan
    n1=en:enzalutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=64
  5. en:finasteride --- r_associated #0: 46 --> en:quadrosilan
    n1=en:finasteride | n2=en:quadrosilan | rel=r_associated | relid=0 | w=46
  6. finastéride --- r_associated #0: 45 --> en:quadrosilan
    n1=finastéride | n2=en:quadrosilan | rel=r_associated | relid=0 | w=45
  7. en:zanoterone --- r_associated #0: 43 --> en:quadrosilan
    n1=en:zanoterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=43
  8. en:5 alpha-reductase inhibitor --- r_associated #0: 40 --> en:quadrosilan
    n1=en:5 alpha-reductase inhibitor | n2=en:quadrosilan | rel=r_associated | relid=0 | w=40
  9. en:avobenzone 20 mg in 1 ml / octinoxate 70 mg in 1 ml / oxybenzone 50 mg in 1 ml topical cream [soothing day spf 15] --- r_associated #0: 35 --> en:quadrosilan
    n1=en:avobenzone 20 mg in 1 ml / octinoxate 70 mg in 1 ml / oxybenzone 50 mg in 1 ml topical cream [soothing day spf 15] | n2=en:quadrosilan | rel=r_associated | relid=0 | w=35
  10. en:dutasteride --- r_associated #0: 35 --> en:quadrosilan
    n1=en:dutasteride | n2=en:quadrosilan | rel=r_associated | relid=0 | w=35
  11. en:androgen receptor antagonist trc253 --- r_associated #0: 34 --> en:quadrosilan
    n1=en:androgen receptor antagonist trc253 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=34
  12. en:androgen receptor inhibitor --- r_associated #0: 34 --> en:quadrosilan
    n1=en:androgen receptor inhibitor | n2=en:quadrosilan | rel=r_associated | relid=0 | w=34
  13. en:ar antagonist odm-201 --- r_associated #0: 34 --> en:quadrosilan
    n1=en:ar antagonist odm-201 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=34
  14. en:cioteronel --- r_associated #0: 32 --> en:quadrosilan
    n1=en:cioteronel | n2=en:quadrosilan | rel=r_associated | relid=0 | w=32
  15. en:androgen receptor antagonist shr3680 --- r_associated #0: 31 --> en:quadrosilan
    n1=en:androgen receptor antagonist shr3680 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=31
  16. en:androgen receptor downregulator azd3514 --- r_associated #0: 31 --> en:quadrosilan
    n1=en:androgen receptor downregulator azd3514 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=31
  17. en:bicalutamide --- r_associated #0: 31 --> en:quadrosilan
    n1=en:bicalutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=31
  18. en:cyp17 inhibitor cfg920 --- r_associated #0: 31 --> en:quadrosilan
    n1=en:cyp17 inhibitor cfg920 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=31
  19. en:inocoterone acetate --- r_associated #0: 31 --> en:quadrosilan
    n1=en:inocoterone acetate | n2=en:quadrosilan | rel=r_associated | relid=0 | w=31
  20. en:abiraterone acetate --- r_associated #0: 30 --> en:quadrosilan
    n1=en:abiraterone acetate | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  21. en:androgen antagonist apc-100 --- r_associated #0: 30 --> en:quadrosilan
    n1=en:androgen antagonist apc-100 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  22. en:cyp17 lyase inhibitor asn001 --- r_associated #0: 30 --> en:quadrosilan
    n1=en:cyp17 lyase inhibitor asn001 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  23. en:hydroxyflutamide --- r_associated #0: 30 --> en:quadrosilan
    n1=en:hydroxyflutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  24. en:steroidal antiandrogen --- r_associated #0: 30 --> en:quadrosilan
    n1=en:steroidal antiandrogen | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  25. en:topterone --- r_associated #0: 30 --> en:quadrosilan
    n1=en:topterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=30
  26. en:androgen receptor antagonist arn-509 --- r_associated #0: 29 --> en:quadrosilan
    n1=en:androgen receptor antagonist arn-509 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=29
  27. en:benorterone --- r_associated #0: 29 --> en:quadrosilan
    n1=en:benorterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=29
  28. en:delanterone --- r_associated #0: 29 --> en:quadrosilan
    n1=en:delanterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=29
  29. en:octinoxate 75 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 25 mg in 1 ml topical cream [matte moisturizer spf 15] --- r_associated #0: 29 --> en:quadrosilan
    n1=en:octinoxate 75 mg in 1 ml / octisalate 40 mg in 1 ml / avobenzone 25 mg in 1 ml topical cream [matte moisturizer spf 15] | n2=en:quadrosilan | rel=r_associated | relid=0 | w=29
  30. en:quillaja saponaria bark --- r_associated #0: 29 --> en:quadrosilan
    n1=en:quillaja saponaria bark | n2=en:quadrosilan | rel=r_associated | relid=0 | w=29
  31. en:abiraterone --- r_associated #0: 28 --> en:quadrosilan
    n1=en:abiraterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=28
  32. en:cyp17 inhibitor vt-464 --- r_associated #0: 28 --> en:quadrosilan
    n1=en:cyp17 inhibitor vt-464 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=28
  33. en:nilandron --- r_associated #0: 28 --> en:quadrosilan
    n1=en:nilandron | n2=en:quadrosilan | rel=r_associated | relid=0 | w=28
  34. en:osaterone --- r_associated #0: 28 --> en:quadrosilan
    n1=en:osaterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=28
  35. en:amadinone --- r_associated #0: 27 --> en:quadrosilan
    n1=en:amadinone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=27
  36. en:ar antagonist bms-641988 --- r_associated #0: 27 --> en:quadrosilan
    n1=en:ar antagonist bms-641988 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=27
  37. en:androgen receptor antagonists --- r_associated #0: 26 --> en:quadrosilan
    n1=en:androgen receptor antagonists | n2=en:quadrosilan | rel=r_associated | relid=0 | w=26
  38. en:androgen receptor inhibitor epi-506 --- r_associated #0: 26 --> en:quadrosilan
    n1=en:androgen receptor inhibitor epi-506 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=26
  39. en:canrenoic acid --- r_associated #0: 26 --> en:quadrosilan
    n1=en:canrenoic acid | n2=en:quadrosilan | rel=r_associated | relid=0 | w=26
  40. en:5-alpha reductase inhibitor [epc] --- r_associated #0: 21 --> en:quadrosilan
    n1=en:5-alpha reductase inhibitor [epc] | n2=en:quadrosilan | rel=r_associated | relid=0 | w=21
  41. en:2-hydroxyflutamide depot --- r_associated #0: 20 --> en:quadrosilan
    n1=en:2-hydroxyflutamide depot | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  42. en:bifluranol --- r_associated #0: 20 --> en:quadrosilan
    n1=en:bifluranol | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  43. en:dimethicone 20 mg/ml topical cream --- r_associated #0: 20 --> en:quadrosilan
    n1=en:dimethicone 20 mg/ml topical cream | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  44. en:enobosarm --- r_associated #0: 20 --> en:quadrosilan
    n1=en:enobosarm | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  45. en:epitestosterone --- r_associated #0: 20 --> en:quadrosilan
    n1=en:epitestosterone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  46. en:nonsteroidal anti-androgens --- r_associated #0: 20 --> en:quadrosilan
    n1=en:nonsteroidal anti-androgens | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  47. en:oral microencapsulated diindolylmethane --- r_associated #0: 20 --> en:quadrosilan
    n1=en:oral microencapsulated diindolylmethane | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  48. en:proxalutamide --- r_associated #0: 20 --> en:quadrosilan
    n1=en:proxalutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  49. en:topilutamide --- r_associated #0: 20 --> en:quadrosilan
    n1=en:topilutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  50. en:triptorelin --- r_associated #0: 20 --> en:quadrosilan
    n1=en:triptorelin | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  51. en:zinc oxide 50 mg/ml rectal cream --- r_associated #0: 20 --> en:quadrosilan
    n1=en:zinc oxide 50 mg/ml rectal cream | n2=en:quadrosilan | rel=r_associated | relid=0 | w=20
  52. Enzalutamide --- r_associated #0: 10 --> en:quadrosilan
    n1=Enzalutamide | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  53. antagoniste du récepteur des androgènes ARN-509 --- r_associated #0: 10 --> en:quadrosilan
    n1=antagoniste du récepteur des androgènes ARN-509 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  54. antagoniste du récepteur des androgènes SHR3680 --- r_associated #0: 10 --> en:quadrosilan
    n1=antagoniste du récepteur des androgènes SHR3680 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  55. antagoniste du récepteur des androgènes TRC253 --- r_associated #0: 10 --> en:quadrosilan
    n1=antagoniste du récepteur des androgènes TRC253 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  56. inhibiteur du récepteur des androgènes --- r_associated #0: 10 --> en:quadrosilan
    n1=inhibiteur du récepteur des androgènes | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  57. inhibiteur du récepteur des androgènes EPI-506 --- r_associated #0: 10 --> en:quadrosilan
    n1=inhibiteur du récepteur des androgènes EPI-506 | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  58. épitestostérone --- r_associated #0: 10 --> en:quadrosilan
    n1=épitestostérone | n2=en:quadrosilan | rel=r_associated | relid=0 | w=10
  59. Finastéride --- r_associated #0: 5 --> en:quadrosilan
    n1=Finastéride | n2=en:quadrosilan | rel=r_associated | relid=0 | w=5
Le service Rézo permet d'énumérer les relations existant pour un terme. Ce service est interrogeable par programme.
Projet JeuxDeMots - url: http://www.jeuxdemots.org
contact: mathieu.lafourcade@lirmm.fr